Investing.com - Molina Healthcare (NYSE: MOH) reported second quarter EPS of $5.86, $0.21 better than the analyst estimate of $5.65. Revenue for the quarter came in at $9.88B versus the consensus estimate of $9.76B.
Guidance
Molina Healthcare sees FY 2024 EPS of $23.50 versus the analyst consensus of $23.34.
Molina Healthcare sees FY 2024 revenue of $38.00B versus the analyst consensus of $39.70B.
Molina Healthcare's stock price closed at $288.72. It is down -15.64% in the last 3 months and down -8.53% in the last 12 months.
Molina Healthcare saw 7 positive EPS revisions and 5 negative EPS revisions in the last 90 days. See Molina Healthcare's stock price’s past reactions to earnings here.
According to InvestingPro, Molina Healthcare's Financial Health score is "great performance".
Check out Molina Healthcare's recent earnings performance, and Molina Healthcare's financials here.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar
Is MOH truely undervalued?
With MOH making headlines, investors are asking: Is it truly valued fairly? InvestingPro's advanced AI algorithms have analyzed MOH alongside thousands of other stocks to uncover hidden gems with massive upside. And guess what? MOH wasn't at the top of the list.
Unlock ProPicks AI